학술논문
MM-364 Elranatamab, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, for Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Extended Follow-Up and Biweekly Administration From the MagnetisMM-3 Study
Document Type
Abstract
Author
Mohty, Mohamad; Tomasson, Michael H.; Arnulf, Bertrand; Bahlis, Nizar J.; Prince, H. Miles; Niesvizky, Ruben; Rodrίguez-Otero, Paula; Martinez-Lopez, Joaquin; Koehne, Guenther; Jethava, Yogesh; Gabayan, Afshin E.; Stevens, Don A.; Nooka, Ajay K.; Raje, Noopur; Iida, Shinsuke; Leip, Eric; Conte, Umberto; Czibere, Akos; Viqueira, Andrea; Lesokhin, Alexander M.
Source
In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S493-S494
Subject
Language
ISSN
2152-2650